Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Situated in Marion, OH, Spero Health provides comprehensive outpatient services, including intensive outpatient programs and treatments with methadone, buprenorphine, or naltrexone for those facing substance abuse challenges. The center emphasizes the importance of anger management, brief interventions, and cognitive behavioral therapy. Specialized programs are available for adult men, adult women, and individuals affected by intimate partner or domestic violence. Catering to both adults and young adults, Spero Health delivers personalized care for all genders. With a commitment to evidence-based practices, this facility guarantees effective support for individuals on their journey to recovery from addiction.
Spero Health, located in Youngstown, OH, provides extensive treatment for substance use disorders with a variety of programs designed to meet the unique needs of each individual. The center focuses on intensive outpatient services, general outpatient care, as well as treatments utilizing methadone, buprenorphine, and naltrexone. Emphasizing techniques such as anger management, brief interventions, and cognitive behavioral therapy, Spero Health supports both adults and young adults, regardless of gender. Additionally, specialized programs are available for adult men, adult women, and those who have faced situations of intimate partner or domestic violence. Spero Health is committed to delivering high-quality, customized care plans to assist individuals on their recovery journey.
Spero Health, located in Canton, OH, specializes in outpatient treatment for individuals grappling with substance use, including both adults and young adults. The center employs a range of methodologies, such as anger management, brief intervention sessions, and cognitive behavioral therapy. They offer tailored programs designed for adult men, adult women, and those who have faced intimate partner or domestic violence. Emphasizing personalized care, Spero Health ensures an inclusive and supportive atmosphere for all clients. If you are looking for effective outpatient treatment options like methadone, buprenorphine, or naltrexone, this facility is committed to aiding individuals as they pursue recovery.
Spero Health, situated in Dublin, VA, specializes in outpatient programs aimed at treating substance use disorders with an emphasis on high-quality, evidence-based care. The center offers various treatment options, including methadone/buprenorphine or naltrexone outpatient services, standard outpatient care, and diverse therapeutic techniques such as anger management, brief intervention, and cognitive behavioral therapy. Spero Health accommodates adult clients, including men and women, as well as those who have faced intimate partner or domestic violence. This facility is committed to delivering personalized and extensive rehabilitation services to assist individuals of all genders, both adults and young adults, on their path to recovery.
Spero Health, located in Madisonville, KY, provides outpatient programs designed for adults and young adults struggling with substance use issues. This center specializes in care for adult males, adult females, and individuals who have faced intimate partner or domestic violence. Treatment methods include anger management, brief intervention strategies, and cognitive behavioral therapy. Spero Health also offers outpatient treatments with methadone, buprenorphine, or naltrexone, complemented by consistent outpatient services. Committed to delivering high-quality care, Spero Health focuses on personalized support for all clients on their journey to recovery from substance use disorders.
Spero Health, located in Lima, OH, provides extensive treatment for substance use through a range of outpatient options, including therapies such as methadone/buprenorphine and naltrexone, as well as anger management, cognitive behavioral therapy, and brief interventions. The center serves both male and female adults, including those who have faced intimate partner violence or domestic abuse. Catering to the needs of adults and young adults, Spero Health delivers personalized care that aligns with each client's unique circumstances. Emphasizing high-quality, evidence-based practices, Spero Health is committed to guiding individuals on their recovery path, with specialized programs designed to create a nurturing and effective atmosphere for all participants.
Spero Health, located in Owensboro, KY, offers outpatient services designed for adults and young adults dealing with substance use issues. This facility provides treatments including methadone, buprenorphine, and naltrexone, alongside regular outpatient services. It incorporates various therapeutic methods such as anger management, brief interventions, and cognitive behavioral therapy. The center features specialized programs for adult men, adult women, and individuals affected by intimate partner or domestic violence. Spero Health is committed to delivering personalized care for both genders, ensuring comprehensive support for clients as they work towards recovery from substance use disorders.
Spero Health, located in Savannah, TN, specializes in outpatient treatment for substance use, emphasizing personalized care and high-quality support. The center offers a variety of services including outpatient treatments with methadone, buprenorphine, or naltrexone, alongside traditional outpatient programs. Additionally, Spero Health incorporates multiple therapeutic methods such as anger management, brief interventions, and cognitive behavioral therapy. This facility serves adult men and women, including those who have faced domestic or intimate partner violence. By focusing on tailored care, Spero Health aims to assist both adults and young adults in their recovery journey.
Spero Health, located in Frankfort, KY, specializes in outpatient treatment for substance use aimed at both adults and young adults. This center offers a variety of targeted services such as outpatient treatments with methadone, buprenorphine, or naltrexone, alongside additional support for anger management, brief interventions, and cognitive behavioral therapy. Emphasizing personalized care, the facility provides programs tailored for adult men, women, and those who have suffered from intimate partner or domestic violence. Spero Health maintains an inclusive atmosphere for all clients, prioritizing their needs. For those in search of effective addiction treatment delivered with empathy, this center is committed to supporting your recovery process.
Spero Health, located in Lancaster, OH, provides comprehensive outpatient services, including intensive outpatient programs and treatment options utilizing methadone, buprenorphine, or naltrexone for those dealing with substance use challenges. Their methodology encompasses therapies such as anger management, cognitive behavioral therapy, and brief intervention strategies. The center features specialized programs catering to adult men and women, as well as those affected by intimate partner or domestic violence. Spero Health serves a diverse clientele of adults and young adults, ensuring that care is personalized to meet the unique requirements of each individual. Committed to evidence-based methods and holistic support, Spero Health strives to help individuals navigate their recovery journey effectively.
Situated in Crossville, TN, Spero Health specializes in outpatient treatment for substance use issues affecting both adults and young adults. The center provides a range of services including methadone, buprenorphine, or naltrexone treatments, as well as regular outpatient programs. Their methods incorporate techniques such as anger management, brief interventions, and cognitive behavioral therapy. Spero Health serves diverse populations, including adult men and women, as well as individuals who have faced intimate partner or domestic abuse. Committed to delivering high-quality care, this facility creates a welcoming atmosphere for individuals of all genders seeking personalized rehabilitation support.
Spero Health, located in Mansfield, OH, delivers an extensive range of substance abuse treatment options, including intensive outpatient programs, standard outpatient services, and medication-assisted treatments with methadone, buprenorphine, or naltrexone. The facility emphasizes therapeutic modalities such as anger management, brief intervention strategies, and cognitive behavioral therapy. Tailored programs are designed for adult men and women, as well as clients who have faced intimate partner or domestic violence. Catering to both adults and young adults of all genders, Spero Health focuses on personalized care that meets the specific needs of each individual. Committed to high standards and evidence-based methodologies, this center strives to support individuals in achieving long-term recovery from substance use issues.
Spero Health, situated in Hopkinsville, KY, focuses on outpatient treatment for substance use disorders affecting both adults and young adults. The center delivers targeted support using methods such as anger management, brief interventions, and cognitive behavioral therapy. Catering to specific groups including adult men, adult women, and individuals who have faced intimate partner or domestic violence, Spero Health is committed to providing personalized care. They offer various outpatient treatment options including methadone, buprenorphine, and naltrexone to meet unique patient needs. With a dedication to quality care for all clients, this center stands out as a trustworthy option for those in need of effective and empathetic addiction recovery services.
Spero Health, located in Jeffersonville, IN, provides outpatient treatment options for substance use disorders specifically designed for adult men and women, including individuals who have faced issues related to intimate partner violence. Emphasizing anger management, brief interventions, and cognitive behavioral therapy, this center delivers focused assistance for those pursuing recovery. Their services are available to adults and young adults of any gender. Spero Health offers outpatient options such as methadone, buprenorphine, or naltrexone treatments in conjunction with standard outpatient programs. The facility is dedicated to delivering high-quality support and care for those working towards sobriety, making it an excellent option for anyone looking for in-depth addiction treatment solutions.
Spero Health, located in Cookeville, TN, specializes in outpatient treatment for substance abuse, emphasizing tailored care for each individual. The center offers a range of services, including outpatient programs for methadone/buprenorphine or naltrexone, standard outpatient therapy, anger management sessions, brief interventions, and cognitive behavioral therapy. It features specialized programs designed for adult men, women, and individuals who have faced intimate partner or domestic violence. Catering to both adults and young adults of any gender, this facility fosters a caring atmosphere for those pursuing recovery from addiction. With its dedication to high-quality care, Spero Health is recognized for its all-encompassing approach to rehabilitation, making it an excellent option for individuals seeking substance abuse treatment.
Spero Health, situated in Danville, VA, provides outpatient care for substance use disorders aimed at adult men, women, and younger adults. The center features tailored programs for individuals affected by intimate partner or domestic violence. Treatment modalities encompass anger management, brief interventions, and cognitive behavioral therapy. Additionally, Spero Health administers outpatient services for methadone, buprenorphine, or naltrexone, alongside standard outpatient treatment. Committed to delivering high-quality care and personalized treatment strategies, this center strives to support individuals in overcoming addiction and attaining sustained recovery.
Spero Health, situated in Roanoke, VA, delivers extensive outpatient services for substance use treatment, featuring options such as methadone/buprenorphine or naltrexone. The center caters to both adult men and women, and is equipped to support clients who have faced domestic or intimate partner violence. Treatment methods encompass anger management, short interventions, and cognitive behavioral therapy. Spero Health is dedicated to providing tailored care and quality assistance for adults and young adults, regardless of gender, who are on the path to recovery from addiction.
Spero Health, located in Seymour, TN, offers extensive outpatient treatment programs for individuals dealing with substance use issues, including both adults and young adults. The center provides various outpatient options, such as methadone, buprenorphine, and naltrexone therapies, alongside standard outpatient services. It emphasizes specific areas like anger management, brief intervention, and cognitive behavioral therapy. Spero Health supports adult men and women, including those who have faced intimate partner or domestic violence. By prioritizing personalized care, the center guarantees high-quality treatment for patients in a nurturing environment, promoting effective recovery solutions.
Spero Health located in Coshocton, OH, provides outpatient treatment for substance use, featuring services like methadone/buprenorphine or naltrexone treatment along with general outpatient care. The center employs various strategies including anger management, brief intervention, and cognitive behavioral therapy. It offers specialized programs designed for adult men and women, as well as those who have faced intimate partner or domestic violence. Spero Health welcomes adults and young adults from all genders, ensuring that each client receives individualized care that meets their specific requirements. Committed to using evidence-based methods and maintaining high standards of treatment, this center strives to assist clients on their recovery paths with care and professionalism.
Situated in Gallipolis, OH, Spero Health stands out as a leading rehabilitation center focused on treatment for substance use disorders. The center provides outpatient services, including methadone, buprenorphine, and naltrexone therapies, alongside traditional outpatient programs. Spero Health also incorporates various therapeutic methods such as anger management and cognitive behavioral therapy, serving adult individuals, including those affected by intimate partner or domestic violence. Catering to all genders, Spero Health emphasizes personalized treatment strategies and utilizes evidence-based practices to ensure quality care. For those in search of supportive and effective addiction recovery options, this center is committed to facilitating your path to healing.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.